Cargando…
Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
BACKGROUND: Disease-modifying drug use necessitates better Alzheimer disease (AD) detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk group; similarly, mild behavioral impairment (MBI) leverages behavioral change. Adding MBI to MCI improves dementia prognostic...
Autores principales: | Ismail, Zahinoor, Leon, Rebeca, Creese, Byron, Ballard, Clive, Robert, Philippe, Smith, Eric E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386685/ https://www.ncbi.nlm.nih.gov/pubmed/37516848 http://dx.doi.org/10.1186/s13024-023-00631-6 |
Ejemplares similares
-
Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults
por: Creese, Byron, et al.
Publicado: (2021) -
Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease
por: Creese, Byron, et al.
Publicado: (2022) -
White matter hyperintensities and mild behavioral impairment: Findings from the MEMENTO cohort study
por: Miao, Ruxin, et al.
Publicado: (2021) -
Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011) -
Late‐life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease
por: Creese, Byron, et al.
Publicado: (2023)